Advances in Cancer Research, Funding Stem Cell Research, and More at Annual Cancer Congress
Posted on: Monday, 29 October 2007, 15:00 CDT
NEW YORK, Oct. 29 /PRNewswire/ -- The "War Against Cancer" continues to make progress with the coming together of over 40 global cancer experts leading the discourse on the latest advances in cancer research and development. The 2008 Global Cancer Congress, scheduled for January 28-29, 2008 in Tampa, Florida will highlight latest R&D innovations in natural products, genomics, stem cells, biomarkers, chemistry and other novel therapeutics, as well as explore "the business of cancer". A pre-conference tutorial workshop will also explore the latest technical and clinical advances in oncofertility preservation.
Headlining the forum will be cancer research industry leaders : -- David L. Keefe, M.D., James M. Ingram Professor and Chairman of the Department of Obstetrics and Gynecology, University of South Florida and Co-Director, Fertility Preservation Services, H. Lee Moffitt Cancer Center & Research Institute -- David J. Newman, Phil Sc., Chief, Natural Products Branch, National Cancer Institute (NCI)-FCRDC -- William G. Thilly, Sc.D., Professor of Biological Engineering, Massachusetts Institute of Technology -- Christopher Milne, D.V.M., M.P.H., J.D., Associate Director, Tufts Center for Drug Development -- Elena V. Gostjeva, Ph.D., Research Scientist, Department of Biological Engineering, Massachusetts Institute of Technology and The Institute of Biotechnology, Kiev, Ukraine
A detailed agenda with complete list of speakers can be found at: http://www.iibig.com/conferences/P0801/agenda.html.
Join iiBIG, our faculty, and especially our local Florida faculty from the University of South Florida, Tampa General Hospital, H. Lee Moffitt Cancer Center & Research Institute, University of Miami, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Scripps Florida and the other Florida organizations to discuss the latest innovations and how to make the business of fighting the war on cancer successful.
Fertile Hope, Embryotech Laboratories, and Transgenomic are early sponsors for this forum. Sponsorship and exhibiting opportunities are limited, but still available. For more information, please contact Kellie Swanstrom, VP Business Development, iiBIG, at 973-571-0867 or kellies@iibig.com.
FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION: Please visit: http://www.iibig.com/P0801 Call: 212-300-2523 E-mail: info@iibig.com
iiBIG
CONTACT: Shelley W. Amster, VP, Pharmaceutical & Life Sciences,International Institute for Business Information & Growth (iiBIG),+1-978-371-5901, Shelleya@iibig.com
Web site: http://www.iibig.com/http://www.iibig.com/P0801http://www.iibig.com/conferences/P0801/agenda.html
Source: PRNewswire
Related Articles
- Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant
- FEI's Titan Krios TEM Selected By Leading Life Science Research Centers in Asia
- Erikson Institute Herr Research Center to Host Policy Conference on Trends and Needs in Early Childhood Mental Health Systems
- South Florida Proton Center to Partner With University of Miami
- NIU Seeks OK for New Proton Cancer Treatment and Research Center
- $20 Million Gift to Establish Cancer Stem Cell Research Center at Stanford
- ProlX Pharmaceuticals Designated Corporate Partner in $5.6 Million Grant to Fund Targeted Therapy Cancer Drug Discovery Research
- Morphotek Announces Collaboration With the John Wayne Cancer Institute for the Development of Antibodies to Treat Melanoma and Lung Cancer
- The Pharmaceutical Institute Launches Research Center With Extensive Library of Pharma and Biotech Industry Books and Market Research
- RedTail Solutions Participates in University of Florida Research Center RFID Pilot to Improve Fresh Produce Supply Chain
 |
 |
User Comments (0)
RSS Feeds